Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05902000Recruiting
Randomised, open-label trial (2 arms). Primary endpoints: Rate of functional independence (mRS <= 2) at 90 days and Rate of symptomatic intracranial hemorrhage at 36 hours. Started Jun 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05902000.